MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026)
MindWalk Holdings (HYFT) reported Enterprise Value of -$10.1 million for Q1 2026, down 11.46% year-over-year from -$11.5 million in Q1 2025, and up 14.79% quarter-over-quarter from -$11.9 million in Q4 2025.
MindWalk Holdings (HYFT) Enterprise Value (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Enterprise Value data on file, last reported at -$10.1 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$10.1 million, down 11.46% year-over-year; the trailing twelve-month figure through Jan 2026 was -$10.1 million (down 11.46% YoY), and the FY2025 annual result was -$7.7 million, down 200.12% from the prior year.
- Enterprise Value improved to -$10.1 million in Q1 2026 per HYFT's latest filing, from -$11.9 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$2.6 million in Q2 2024 and troughed at -$26.1 million in Q1 2022.
- A 5-year average of -$9.1 million and a median of -$7.5 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2023 and 2025: Enterprise Value jumped 73.94% in 2023, then plunged 359.84% in 2025.
- A 5-year view of Enterprise Value shows it stood at -$11.3 million in 2022, then soared by 60.86% to -$4.4 million in 2023, then surged by 41.68% to -$2.6 million in 2024, then tumbled by 359.84% to -$11.9 million in 2025, then rose by 14.79% to -$10.1 million in 2026.
- Business Quant data shows HYFT's Enterprise Value at -$10.1 million in Q1 2026, -$11.9 million in Q4 2025, and -$3.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.77 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -18.44 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -584.73 Mn |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -10.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -10.14 Mn |
| Oct 31, 2025 | -11.90 Mn |
| Jul 31, 2025 | -3.56 Mn |
| Apr 30, 2025 | -7.49 Mn |
| Jan 31, 2025 | -9.10 Mn |
| Oct 31, 2024 | -2.59 Mn |
| Jul 31, 2024 | -2.86 Mn |
| Apr 30, 2024 | -2.55 Mn |
| Jan 31, 2024 | -4.59 Mn |
| Oct 31, 2023 | -4.44 Mn |
| Jul 31, 2023 | -5.04 Mn |
| Apr 30, 2023 | -6.18 Mn |
| Jan 31, 2023 | -8.40 Mn |
| Oct 31, 2022 | -11.34 Mn |
| Jul 31, 2022 | -14.96 Mn |
| Apr 30, 2022 | -23.72 Mn |
| Jan 31, 2022 | -26.06 Mn |
| Oct 31, 2021 | -30.51 Mn |
| Jul 31, 2021 | -33.13 Mn |
| Apr 30, 2021 | -33.23 Mn |